26 August – Webinar in connection with year-end report
On 26 August 2026, Alligator hosted a webinar for investors, analysts and media, where CEO Søren Bregenholt and CFO Johan Giléus presented and commented on the 2026 April-June interim report, which was followed by a Q&A session.
The call was held in English. A recording can be found on Alligator’s Youtube channel.
LATEST NEWS
Alligator Bioscience publishes prospectus in connection with rights issue
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, …
Bulletin from the extraordinary general meeting in Alligator Bioscience AB
Today, on 26 August 2026, an extraordinary general meeting was held in Alligator Bioscience AB. A summary of the adopted resolutions follows …
Alligator Bioscience AB reports financial results for the period 1 January – 30 June 2026 and provides a business update
Strategic refocus: After the quarter, Alligator discontinued all further independent development of mitazalimab and refocused on preserving …